Our latest review with @doctorpaf.bsky.social! We discuss the breadth of therapeutic potential for the neurodegenerative enzyme SARM1.

-Challenges for SARM1 inhibition for neuroprotection
-Roles in non-neuronal cells
-SARM1 activation for selective peripheral neuroablation

dlvr.it/TNnCBh

We’re hiring! Join the Sivyer Lab at The University of Sydney as a Postdoctoral Research Fellow in Neurodegeneration within the Snow Vision Accelerator, a $50M initiative tackling glaucoma and optic nerve disease. iPSCs, electrophysiology, drug discovery, and gene therapy.

www.snowmedical.org.au/vision-accel... Today marks the official beginning of the Snow Vision Accelerator, a ten year investment by the SMRF that will enable us to protect the optic nerve in glaucoma. A huge thank you to SMRF and the Snow Family. #SVA #SMRF #USYD #glaucoma #opticnerve #MIPS

The good news for today, scientifically speaking for vision research is that the NEI appears to have survived the budget reconciliation process in the House. And the NIH budget was not decreased.

This still has to go to the Senate, but the National Eye Institute still lives in the House bill...

Honoured to be a Silver Fellow of @arvoinfo.bsky.social It’s been so rewarding being involved in ARVO! Excited to sink my teeth into the next annual meeting in Denver! #ARVO2025

With all the chaos and destruction of academic research going on in the US right now, it feels a little weird to post this. But....

New preprint from the lab is now live: www.biorxiv.org/content/10.1...

1/n